QUIDELORTHO CORP Basic Shares Outstanding (Weighted Average)
QUIDELORTHO CORP (QDEL) reported Basic Shares Outstanding (Weighted Average) of 68.30 million shares for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-07
- QUIDELORTHO CORP weighted average number of shares outstanding, basic for the quarter ending 2026-06-28 was 68.30M shares, a 0.89% increase year-over-year.
- QUIDELORTHO CORP weighted average number of shares outstanding, basic for the quarter ending 2026-03-29 was 68.20M shares, a 1.04% increase year-over-year.
- QUIDELORTHO CORP weighted average number of shares outstanding, basic for the quarter ending 2025-12-28 was 68.10M shares, a 0.89% increase year-over-year.
- QUIDELORTHO CORP weighted average number of shares outstanding, basic for the quarter ending 2025-09-28 was 68.00M shares, a 1.04% increase year-over-year.
- QUIDELORTHO CORP weighted average number of shares outstanding, basic for fiscal 2025 was 67.80M shares, a 0.89% increase from fiscal 2024.
- QUIDELORTHO CORP weighted average number of shares outstanding, basic for fiscal 2024 was 67.20M shares, a 0.60% increase from fiscal 2023.
- QUIDELORTHO CORP weighted average number of shares outstanding, basic for fiscal 2023 was 66.80M shares, a 17.61% increase from fiscal 2023.
- QUIDELORTHO CORP weighted average number of shares outstanding, basic for fiscal 2023 was 56.80M shares, a 34.92% increase from fiscal 2022.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-28 | 68.30M shares 10-Q · filed 2026-08-07 | 68.20M shares 10-Q · filed 2026-08-07 | 68.20M shares derived: average of 3 quarters · filed 2026-08-07 | 68.15M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2026-03-29 | 68.20M shares 10-Q · filed 2026-05-06 | 68.15M shares derived: average of 2 quarters · filed 2026-05-06 | 68.10M shares derived: average of 3 quarters · filed 2026-05-06 | 68.00M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2025-12-28 | 68.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | 68.05M shares derived: average of 2 quarters · filed 2026-02-19 | 67.93M shares derived: average of 3 quarters · filed 2026-08-07 | 67.80M shares 10-K · filed 2026-02-19 |
| 2025-09-28 | 68.00M shares 10-Q · filed 2025-11-06 | 67.85M shares derived: average of 2 quarters · filed 2026-08-07 | 67.70M shares 10-Q · filed 2025-11-06 | 67.67M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2025-06-29 | 67.70M shares 10-Q · filed 2026-08-07 | 67.60M shares 10-Q · filed 2026-08-07 | 67.57M shares derived: average of 3 quarters · filed 2026-08-07 | 67.50M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2025-03-30 | 67.50M shares 10-Q · filed 2026-05-06 | 67.50M shares derived: average of 2 quarters · filed 2026-05-06 | 67.43M shares derived: average of 3 quarters · filed 2026-05-06 | 67.35M shares derived: average of 4 quarters · filed 2026-05-06 |
| 2024-12-29 | 67.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | 67.40M shares derived: average of 2 quarters · filed 2026-02-19 | 67.30M shares derived: average of 3 quarters · filed 2026-02-19 | 67.20M shares 10-K · filed 2026-02-19 |
| 2024-09-29 | 67.30M shares 10-Q · filed 2025-11-06 | 67.20M shares derived: average of 2 quarters · filed 2025-11-06 | 67.10M shares 10-Q · filed 2025-11-06 | 67.03M shares derived: average of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | 67.10M shares 10-Q · filed 2025-08-06 | 67.00M shares 10-Q · filed 2025-08-06 | 66.93M shares derived: average of 3 quarters · filed 2026-02-19 | 66.92M shares derived: average of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | 66.90M shares 10-Q · filed 2025-05-08 | 66.85M shares derived: average of 2 quarters · filed 2026-02-19 | 66.87M shares derived: average of 3 quarters · filed 2026-02-19 | 66.85M shares derived: average of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | 66.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | 66.85M shares derived: average of 2 quarters · filed 2026-02-19 | 66.83M shares derived: average of 3 quarters · filed 2026-02-19 | 66.80M shares 10-K · filed 2026-02-19 |
| 2023-10-01 | 66.90M shares 10-Q · filed 2024-11-08 | 66.85M shares derived: average of 2 quarters · filed 2024-11-08 | 66.80M shares 10-Q · filed 2024-11-08 | 66.67M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-07-02 | 66.80M shares 10-Q · filed 2024-08-01 | 66.70M shares 10-Q · filed 2024-08-01 | 66.60M shares derived: average of 3 quarters · filed 2025-02-27 | 66.67M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-04-02 | 66.60M shares 10-Q · filed 2024-05-09 | 66.50M shares derived: average of 2 quarters · filed 2025-02-27 | 66.63M shares derived: average of 3 quarters · filed 2025-02-27 | 63.02M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-01-01 | 66.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 66.65M shares derived: average of 2 quarters · filed 2025-02-27 | 61.83M shares derived: average of 3 quarters · filed 2025-02-27 | 56.80M shares 10-K · filed 2025-02-27 |
| 2022-10-02 | 66.90M shares 10-Q · filed 2023-11-02 | 59.55M shares derived: average of 2 quarters · filed 2023-11-02 | 53.60M shares 10-Q · filed 2023-11-02 | 51.08M shares derived: average of 4 quarters · filed 2024-08-01 |
| 2022-07-03 | 52.20M shares 10-Q · filed 2023-08-09 | 47.00M shares 10-Q · filed 2023-08-09 | 45.80M shares derived: average of 3 quarters · filed 2024-08-01 | 44.77M shares derived: average of 4 quarters · filed 2024-08-01 |
| 2022-04-03 | 41.90M shares 10-Q · filed 2023-05-04 | 42.60M shares derived: average of 2 quarters · filed 2024-08-01 | 42.30M shares derived: average of 3 quarters · filed 2024-08-01 | 42.15M shares derived: average of 4 quarters · filed 2024-08-01 |
| 2022-01-02 | 43.30M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | 42.50M shares derived: average of 2 quarters · filed 2024-08-01 | 42.23M shares derived: average of 3 quarters · filed 2024-08-01 | 42.10M shares 10-K/A · filed 2024-08-01 |
| 2021-10-03 | 41.70M shares 10-Q · filed 2022-11-04 | 41.70M shares derived: average of 2 quarters · filed 2022-11-04 | 41.70M shares 10-Q · filed 2022-11-04 | |
| 2021-07-04 | 41.70M shares 10-Q · filed 2022-08-05 | 41.60M shares 10-Q · filed 2022-08-05 | ||
| 2021-01-03 | 42.10M shares 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |